Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Study of Infliximab for Treatment Resistant Major Depression
Read the official source — NCT00463580This study evaluated the effectiveness of Infliximab for people with depression.
This study has finished and is no longer accepting participants.
In AtlantaA Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Treatment-resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamResearchers compared JNJ-55308942 and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
This study has finished and is no longer accepting participants.
Multiple locations, including HuntsvilleThis study evaluated the safety and effectiveness of JNJ-61393215 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveResearchers compared JZP150 and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixA Phase 1, Healthy Volunteer Qualification Of Ligand [11C] PF-04767135 And Randomized Determination Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET
This study ended early.
In New HavenPilot study evaluating the efficacy of subcutaneous ketamine for the treatment of depression in the elderly.
This study was withdrawn before enrollment.
In New ZealandA Double-blind, Randomized, Placebo-controlled, Parallel Group, Dose Frequency Study of Ketamine in Subjects With Treatment-resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamThis study assesses depression symptoms.
This study ended early.
In Jacksonville
Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan: A Retrospective Cohort Study of Label Compliance
This study has finished and is no longer accepting participants.
In TitusvilleA Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Read the official source — NCT00210691Risperidone Depot (Microspheres) in the Treatment of Subjects With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers studied Lurasidone, tracking side effects to assess safety in people with schizophrenia.
This study has finished and is no longer accepting participants.
In TaipeiWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.